ZNF136 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.00929994864651E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.63560004323915E-09 |
Normal-vs-Stage2 |
4.36160000000241E-05 |
Normal-vs-Stage3 |
2.04979999973709E-07 |
Normal-vs-Stage4 |
5.89360005243122E-09 |
Stage1-vs-Stage2 |
8.825000E-01 |
Stage1-vs-Stage3 |
3.906600E-01 |
Stage1-vs-Stage4 |
3.663700E-02 |
Stage2-vs-Stage3 |
4.146200E-01 |
Stage2-vs-Stage4 |
2.604000E-02 |
Stage3-vs-Stage4 |
1.107350E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.60150001540893E-09 |
Normal-vs-AfricanAmerican |
6.54820000001166E-07 |
Normal-vs-Asian |
4.70809999997268E-06 |
Caucasian-vs-AfricanAmerican |
9.959000E-01 |
Caucasian-vs-Asian |
1.583370E-01 |
AfricanAmerican-vs-Asian |
1.341990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.97599977783625E-10 |
Normal-vs-Female |
1.013980E-04 |
Male-vs-Female |
4.256300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.97980000008025E-07 |
Normal-vs-Extreme_Weight |
1.30489996585936E-09 |
Normal-vs-Obese |
1.50180000002553E-06 |
Normal-vs-Extreme_Obese |
4.2914000000227E-06 |
Normal_Weight-vs-Extreme_Weight |
9.172800E-01 |
Normal_Weight-vs-Obese |
2.523400E-01 |
Normal_Weight-vs-Extreme_Obese |
5.816600E-01 |
Extreme_Weight-vs-Obese |
1.417170E-01 |
Extreme_Weight-vs-Extreme_Obese |
5.989000E-01 |
Obese-vs-Extreme_Obese |
1.856220E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.436760E-04 |
Normal-vs-Age(41-60Yrs) |
3.29749999972151E-07 |
Normal-vs-Age(61-80Yrs) |
2.89590018631714E-10 |
Normal-vs-Age(81-100Yrs) |
7.07440000025095E-07 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.795600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.610800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.236000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.426400E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.665420E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.704400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
8.51610004737324E-09 |
Normal-VS-Type2 PRCC |
6.31383834104327E-13 |
Normal-VS-KIRP CIMP |
5.484800E-03 |
Normal-VS-Unclassified PRCC |
2.782800E-03 |
Type1 PRCC-VS-Type2 PRCC |
4.876500E-03 |
Type1 PRCC-VS-KIRP CIMP |
2.171400E-01 |
Type1 PRCC-VS-Unclassified PRCC |
2.230400E-01 |
Type2 PRCC-VS-KIRP CIMP |
9.466600E-01 |
Type2 PRCC-VS-Unclassified PRCC |
9.198400E-03 |
KIRP CIMP-VS-Unclassified PRCC |
1.482220E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.02078370598247E-12 |
Normal-vs-N1 |
1.400410E-04 |
Normal-vs-N2 |
1.75960357395866E-11 |
N0-vs-N1 |
4.317400E-01 |
N0-vs-N2 |
8.45489999999893E-05 |
N1-vs-N2 |
6.582700E-04 |
|
|